GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
A single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles
was reported to increase pregnancy and birth rates. This study was done to evaluate the
reproducibility of previous findings.